|
30/10/2024
|
07:00
|
R&D Spotlight focusing on pipeline advances
|
RNS
|
|
28/10/2024
|
07:00
|
Block Listing Six Monthly Return
|
RNS
|
|
24/10/2024
|
07:00
|
Avacta Reports Pipeline Avances at EORTC
|
RNS
|
|
21/10/2024
|
16:00
|
Issue of Equity and Total Voting Rights
|
RNS
|
|
21/10/2024
|
07:00
|
Avacta and Tempus Enter Strategic Collaboration
|
RNS
|
|
17/10/2024
|
07:00
|
Avacta Expands its Pipeline
|
RNS
|
|
15/10/2024
|
07:00
|
Avacta appoints Chief Scientific Officer
|
RNS
|
|
10/10/2024
|
07:00
|
Avacta Unveils Pipeline Expansion at EORTC 2024
|
RNS
|
|
30/09/2024
|
07:00
|
Interim Results
|
RNS
|
|
16/09/2024
|
07:00
|
Avacta Reported Updated Phase 1 Data of AVA6000
|
RNS
|
|
12/09/2024
|
07:00
|
Notice of Results
|
RNS
|
|
09/09/2024
|
07:00
|
Avacta to present clinical data at ESMO Congress
|
RNS
|
|
02/09/2024
|
15:53
|
Director/PDMR Shareholdings and TVR
|
RNS
|
|
18/07/2024
|
07:00
|
Convertible Bond Payment
|
RNS
|
|
26/06/2024
|
14:46
|
Result of AGM
|
RNS
|
|
26/06/2024
|
07:00
|
AGM Business Update
|
RNS
|
|
20/06/2024
|
07:00
|
Shaun Chilton appointed Non-Executive Chairman
|
RNS
|
|
11/06/2024
|
07:00
|
Appointment of Nominated Adviser and Sole Broker
|
RNS
|
|
31/05/2024
|
07:00
|
Posting of Annual Report and Notice of AGM
|
RNS
|
|
23/05/2024
|
07:00
|
Successful Completion of First Cohort
|
RNS
|
|
30/04/2024
|
07:01
|
Full Year Results
|
RNS
|
|
30/04/2024
|
07:00
|
Board Change
|
RNS
|
|
26/04/2024
|
09:51
|
Block listing Interim Return REPLACEMENT
|
RNS
|
|
26/04/2024
|
07:00
|
Block Listing Six Monthly Return
|
RNS
|
|
23/04/2024
|
09:43
|
Block Listing Application to AIM
|
RNS
|
|
23/04/2024
|
07:00
|
Notice of Results
|
RNS
|
|
22/04/2024
|
12:14
|
Issue of Equity and Total Voting Rights
|
RNS
|
|
09/04/2024
|
17:00
|
Avacta Reports Data at the AACR Annual Meeting
|
RNS
|
|
08/04/2024
|
07:00
|
AVA6000 Abstract Release by AACR
|
RNS
|
|
21/03/2024
|
07:00
|
Update on AVA6000 Phase 1a Clinical Trial Progress
|
RNS
|
|
18/03/2024
|
13:26
|
Result of General Meeting
|
RNS
|
|
06/03/2024
|
07:00
|
Avacta Announces AVA6000 Poster at AACR
|
RNS
|
|
05/03/2024
|
07:00
|
Result of REX Retail Offer
|
RNS
|
|
29/02/2024
|
07:00
|
Result of Placing
|
RNS
|
|
28/02/2024
|
16:42
|
Proposed REX Retail Offer
|
RNS
|
|
28/02/2024
|
16:41
|
Proposed Fundraise to progress Therapeutics
|
RNS
|
|
16/02/2024
|
07:00
|
Share Incentive Plan/Issue of Equity
|
RNS
|
|
22/01/2024
|
10:51
|
Issue of Equity and Total Voting Rights
|
RNS
|
|
19/01/2024
|
07:00
|
Appointment of Christina Coughlin
|
RNS
|
|
19/12/2023
|
07:00
|
Appointment of Chief Business Officer
|
RNS
|
|
13/12/2023
|
07:00
|
ALS-6000-101 Phase 1a Study Data
|
RNS
|
|
04/12/2023
|
07:00
|
Shareholder update to review AVA6000 Phase 1a data
|
RNS
|
|
27/10/2023
|
07:00
|
Block Listing Six Monthly Return
|
RNS
|
|
23/10/2023
|
13:30
|
Issue of Equity and Total Voting Rights
|
RNS
|
|
18/10/2023
|
13:00
|
Block Listing Application to AIM
|
RNS
|
|
05/10/2023
|
07:00
|
Avacta to present at AACR-NCI-EORTC conference
|
RNS
|
|
28/09/2023
|
07:00
|
Interim Results for the Period Ending 30 June 2023
|
RNS
|
|
20/09/2023
|
14:00
|
Issue of Equity and Total Voting Rights
|
RNS
|
|
20/09/2023
|
07:01
|
Peel Hunt Appointed as Joint Broker
|
RNS
|
|
20/09/2023
|
07:00
|
Appointment Dr.Christina Coughlin as a consultant
|
RNS
|